SIALIDASE ACTIVITY OF THE STREPTOCOCCUS-MILLERI GROUP AND OTHER VIRIDANS GROUP STREPTOCOCCI

被引：64
|
作者：
BEIGHTON, D [1 ]
WHILEY, RA [1 ]
机构：
[1] UNIV LONDON LONDON HOSP,COLL MED,DEPT ORAL MICROBIOL,LONDON E1 2AD,ENGLAND
来源：
JOURNAL OF CLINICAL MICROBIOLOGY | 1990年 / 28卷 / 06期
关键词：
D O I：
10.1128/JCM.28.6.1431-1433.1990
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页码：1431 / 1433
页数：3
相关论文
共 50 条
  • [21] Lung Abscesses in 2 Patients With Lancefield Group F Streptococci (Streptococcus milleri Group)
    Gogineni, Vijaya K.
    Modrykamien, Ariel
    RESPIRATORY CARE, 2011, 56 (12) : 1966 - 1969
  • [22] Comparative transcriptomic analysis of streptococcus pseudopneumoniae with viridans group streptococci
    Park, Hee Kuk
    Myung, Soon Chul
    Kim, Wonyong
    BMC MICROBIOLOGY, 2012, 12
  • [23] Comparative transcriptomic analysis of streptococcus pseudopneumoniae with viridans group streptococci
    Hee Kuk Park
    Soon Chul Myung
    Wonyong Kim
    BMC Microbiology, 12
  • [24] PANSINUSITIS, ORBITAL CELLULITIS, MENINGITIS, AND SUBDURAL EMPYEMA DUE TO STREPTOCOCCUS-MILLERI GROUP
    SYED, S
    WEATHERS, S
    JAFFE, P
    MUSHER, D
    INFECTIOUS DISEASES IN CLINICAL PRACTICE, 1994, 3 (06) : 454 - 457
  • [25] ISOLATION OF STREPTOCOCCUS-MILLERI GROUP FROM OROFACIAL INFECTIONS AND ASSOCIATION WITH PREVOTELLA SPECIES
    LEWIS, MAO
    WILSON, MJ
    BHSOP, PA
    JOURNAL OF DENTAL RESEARCH, 1995, 74 (03) : 853 - 853
  • [26] Variants of the bile: solubility test to differentiate Streptococcus pneumoniae from other viridans group streptococci
    Ercibengoa, Maria
    Morales, Maria
    Alonso, Marta
    Ardanuy, Carmen
    Marimon, Jose M.
    FUTURE MICROBIOLOGY, 2019, 14 (11) : 949 - 955
  • [27] Assessment of the Optochin Susceptibility Test to Differentiate Streptococcus pneumoniae from other Viridans Group Streptococci
    Ercibengoa, Maria
    CLINICAL LABORATORY, 2021, 67 (03) : 857 - 861
  • [28] Activity of DX-619 compared to other agents against viridans group streptococci, Streptococcus bovis, and Cardiobacterium hominis
    Kosowska-Shick, KJaudia
    Smith, Kathy
    Bogdanovich, Tatiana
    Ednie, Lois M.
    Jones, Ronald N.
    Appelbaum, Peter C.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (12) : 4191 - 4194
  • [29] INCIDENCE AND CHARACTERIZATION OF BETA-HEMOLYTIC STREPTOCOCCUS-MILLERI AND DIFFERENTIATION FROM STREPTOCOCCUS-PYOGENES (GROUP-A), STREPTOCOCCUS-EQUISIMILIS (GROUP-C), AND LARGE-COLONY GROUP-G STREPTOCOCCI
    LAWRENCE, J
    YAJKO, DM
    HADLEY, WK
    JOURNAL OF CLINICAL MICROBIOLOGY, 1985, 22 (05) : 772 - 777
  • [30] POTENTIAL PATHOGENIC PROPERTIES OF MEMBERS OF THE STREPTOCOCCUS-MILLERI GROUP IN RELATION TO THE PRODUCTION OF ENDOCARDITIS AND ABSCESSES
    WILLCOX, MDP
    JOURNAL OF MEDICAL MICROBIOLOGY, 1995, 43 (06) : 405 - 410
12345